EUDRACAP
LIVE

Serial Number

79297401

Owner

Evonik Operations GmbH

Attorney

Scott D. Woldow

Filing Date

May 15, 2020

Add to watchlist:

No watchlists yet
View on USPTO

EUDRACAP Trademark

Serial Number: 79297401 • Registration: 6350881

EUDRACAP is a trademark filed by Evonik Operations GmbH on May 15, 2020. The trademark is classified under Class 1 (Chemicals), Class 2 (Paints), Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Evonik Operations GmbH (3 trademarks)

Rellinghauser Str. 1-11

Entity Type: 16

Trademark Details

Filing Date

May 15, 2020

Registration Date

May 18, 2021

Published for Opposition

March 2, 2021

Goods & Services

Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry, with the exception of fertilizers, fungicides, herbicides, insecticides and parasiticides; chemical auxiliaries and intermediate products, namely, chemical additives for the manufacture of pharmaceutical and cosmetic products; unprocessed artificial resins, unprocessed plastics, unprocessed artificial resins in the form of powders, granules, solutions, emulsions, dispersions, and pastes, in particular for use as auxiliaries for the manufacture of pharmaceutical products; biodegradable polymers for the manufacture of medical and pharmaceutical preparations; acrylic polymers for the manufacture of medical and pharmaceutical preparations; industrial chemicals, namely, polymethymethacrylate; industrial chemicals, namely, lactides; industrial chemicals, namely, glycolides; industrial chemicals, namely, dioxanones and trimethylencarbonates; industrial chemicals, namely, caprolactones; chemical substances for preserving foodstuffs; adhesives used in industry

Pharmaceutical and veterinary preparations for the treatment of colon, gastro-intestinal and upper bowel diseases, illnesses and conditions; Pharmaceutical and veterinary preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Medical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; adjuvants for medical purposes; Drug delivery agents in the form of coatings, lacquers and glazes for pharmaceutical, veterinary and dietary preparations that facilitate the delivery of a wide range of pharmaceuticals; chemical preparations for medical, pharmaceutical, veterinary and hygienic purposes, namely, drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; chemical preparations for veterinary purposes, namely, drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; chemical preparations for sanitary purposes; esters for pharmaceutical purposes; diagnostic agents for medical use; chewing gum for medical purposes; gamboge for medical purposes; chemico-pharmaceutical preparations, namely, drug delivery agents in the form of a coating in granule, powder, aqueous solution and organic solution form to facilitate the delivery of a wide range of pharmaceuticals; surgical implants comprised of living tissues; capsules for medicines, namely, capsules sold empty for pharmaceuticals; sanitary preparations for medical purposes; sanitary preparations and articles, namely, chemical preparations for sanitary use; dietetic foodstuffs and preparations for medical and veterinary purposes namely, dietetic sugar for medical or veterinary use; dietary supplements and dietetic preparations, namely, nutritional supplements; dietetic substances for medical purposes; infant formula; medical plasters; materials for wound dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying noxious animals; fungicides; herbicides; Drug delivery agents in the form of lacquers and glazes for pharmaceutical and veterinary preparations that facilitate the delivery of a wide range of pharmaceuticals

Scientific and technological services, namely, research and design in the field of chemical and pharmaceutical development; industrial research services in the field of chemical and pharmaceutical products; design and development of computer hardware and software; technical consultancy in the field of the manufacture of chemical, pharmaceutical and veterinary preparations using chemical and pharmaceutical polymers; technical consultancy in the field of the use of biodegradable polymers for medical applications; quality control and material testing; technological consultancy relating to technical research in the field of chemical and pharmaceutical research and development and preparation of related reports; materials testing and analysis; chemist services; engineering services; scientific bacteriological and chemical laboratory services; consultancy in the field of physics

Dyes and inks used in the manufacture of medical and pharmaceutical preparations; colorants, pigments; food and beverage colorings; thinners and thickeners for coatings being paint, dyes, and inks; coatings being paints; metals in foil and powder form for use in painting, decorating, printing and art; paints and washes being coatings in the nature of stains; varnishes; wood preservatives; raw natural resins; lacquers for use in industry; Mordant dyes; dry inks

Treatment of materials, namely, processing and formulation of chemical and pharmaceutical polymers for the manufacture of chemical, pharmaceutical and veterinary preparations; custom manufacture of chemical, pharmaceutical and veterinary preparations for others by means of microencapsulating techniques; treatment of materials, namely, processing and formulation of biodegradable polymers for medical applications, in particular tissue replacement, bone formation and bone fixation as well as for the manufacture of chemical, pharmaceutical and veterinary preparations; treatment of materials, namely, processing and formulation of chemical and pharmaceutical preparations for the controlled release of active ingredients in chemical, pharmaceutical and veterinary preparations; treatment of materials, namely, processing and formulation of chemical and pharmaceutical preparations used for surgical, medical, dental and veterinary apparatus and instruments as well as diagnostic apparatus for medical use and apparatus for use in medical analysis; treatment of materials, namely, processing and formulation of biodegradable polymers for the manufacture of artificial limbs, artificial implants, stents, syringes for medical purposes, catheters, cannulae, acupuncture needles, surgical needles, artificial limbs, eyes and teeth, medical guidewires, orthopedic articles, suture materials

Medical services; veterinary services; hygienic and beauty care for human beings or animals; horticulture services; agricultural advice; pest control for forestry; pharmaceutical services in field of the manufacture of pharmaceuticals, namely, pharmaceutical compounding services for others

Filing History

TEAS SECTION 71 RECEIVED
Jun 2, 2026 ES71
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
May 18, 2026 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Oct 4, 2021 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Sep 8, 2021 FICS
FINAL DISPOSITION PROCESSED
Sep 8, 2021 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Aug 18, 2021 FICR
REGISTERED-PRINCIPAL REGISTER
May 18, 2021 R.PR
NOTIFICATION PROCESSED BY IB
Mar 15, 2021 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 2, 2021 NPUB
PUBLISHED FOR OPPOSITION
Mar 2, 2021 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Feb 24, 2021 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Feb 24, 2021 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 10, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 22, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 21, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 21, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 21, 2021 TROA
REFUSAL PROCESSED BY IB
Dec 27, 2020 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Dec 4, 2020 RFCS
REFUSAL PROCESSED BY MPU
Dec 3, 2020 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 17, 2020 RFCR
NON-FINAL ACTION WRITTEN
Nov 16, 2020 CNRT
APPLICATION FILING RECEIPT MAILED
Nov 13, 2020 MAFR
ASSIGNED TO EXAMINER
Nov 9, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 9, 2020 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Nov 5, 2020 REPR